MindMed (MNMD)

• Market cap: $418M
• 1 day: -5.30%
• 5 days: -18.53%
• 1 month: -8.73%
• 3 months: -26.53%
• 6 months: -1.60%
• Year to date: -26.53%
• 1 year: -41.81%
• 5 years: -90.81%
• 10 years: -90.81%
• Sector: Healthcare
• Industry: Medicinal Chemicals & Botanical Products

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

196% more call options, than puts

Call options by funds: $14.5M | Put options by funds: $4.88M

85% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 20

79% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 33

50% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 3 (+1) [Q4]

10% more funds holding

Funds holding: 156 [Q3] → 171 (+15) [Q4]

6% more capital invested

Capital invested by funds: $282M [Q3] → $300M (+$18.1M) [Q4]

4.14% less ownership

Funds ownership: 60.87% [Q3] → 56.72% (-4.14%) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $16 189% upside
• Avg. target: $31 466% upside
• High target: $55 893% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Baird Joel Beatty 45% 1-year accuracy 18 / 40 met price target	189% upside $16	Outperform Maintained	7 Mar 2025
HC Wainwright & Co. Patrick Trucchio 21% 1-year accuracy 38 / 181 met price target	893% upside $55	Buy Reiterated	7 Mar 2025
Evercore ISI Group Gavin Clark-Gartner 27% 1-year accuracy 3 / 11 met price target	315% upside $23	Outperform Initiated	28 Jan 2025